Concepedia

Author

Barbara Eichhorst

University of CologneORCID

Also Known As

B Eichhorst, B. Eichhorst, B. F. Eichhorst, B.F Eichhorst, BARBARA EICHHORST, Barbara Eichhorst, Barbara F Eichhorst, Barbara F. Eichhorst, Eichhorst B, Kieron Dunleavy

436

Publications

21.3K

Citations

61

H-Index

81

Concepts

All Affiliations

University of CologneUniversity Hospital CologneUniversität UlmMünchen Klinik SchwabingUniversity Hospital Ulm
BE

About

Barbara Eichhorst is an author at University of Cologne specializing in medicine, oncology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

28

47

5K

2

Health Sciences

14

20

1K

3

Public Health

2

2

248

4

Engineering

1

1

118

5

Biochemistry

1

1

32

Barbara Eichhorst

×

149

Publications

19.2K

Citations

59

H-Index

YearCitations

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

Michael Hallek, Bruce D. Cheson, Daniel Catovsky,

Blood

2018

1.6K

Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions

Valentin Goede, Kirsten Fischer, Raymonde Busch,

New England Journal of Medicine

2014

1.5K

Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

John F. Seymour, Thomas J. Kipps, Barbara Eichhorst,

New England Journal of Medicine

2018

881

Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions

Kirsten Fischer, Othman Al‐Sawaf, Jasmin Bahlo,

New England Journal of Medicine

2019

816

Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study

Stephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig,

The Lancet Oncology

2016

783

Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial

Kirsten Fischer, Jasmin Bahlo, Anna Maria Fink,

Blood

2015

693

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial

Barbara Eichhorst, Anna‐Maria Fink, Jasmin Bahlo,

The Lancet Oncology

2016

613

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Barbara Eichhorst, Tadeusz Robak, Emili Montserrat,

Annals of Oncology

2015

590

<i>TP53</i> Mutation and Survival in Chronic Lymphocytic Leukemia

Thorsten Zenz, Barbara Eichhorst, Raymonde Busch,

Journal of Clinical Oncology

2010

587

Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia

Barbara Eichhorst

Blood

2005

587

Page 1